2014
DOI: 10.1007/s40005-014-0154-z
|View full text |Cite
|
Sign up to set email alerts
|

Advances in investigations on the mechanism of cancer multidrug resistance and the liposomes-based treatment strategy

Abstract: Multidrug resistance is a major cause that leads to the refractory of cancers after a combination strategy by chemotherapy, radiation and surgical treatment. Among the comprehensive treatment, chemotherapy still plays a crucial role in eliminating malignant cells. The objectives of present review were to elucidate the research advances in the mechanism of cancer multidrug resistance and the liposomes-based treatment strategy. The drug resistance could be related to cancer cells, heterogeneity, microenvironment… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 82 publications
0
5
0
Order By: Relevance
“…Currently, 3D tumor spheroids are more widely utilized for in vitro drug testing than the conventional 2D culture models in which cancer cells usually show higher drug sensitivity [51] , [52] , [53] . We observed decreased sensitivity to sorafenib in Huh-7 spheroids than in cells grown as 2D monolayers ( Figure 5 A ).…”
Section: Discussionmentioning
confidence: 99%
“…Currently, 3D tumor spheroids are more widely utilized for in vitro drug testing than the conventional 2D culture models in which cancer cells usually show higher drug sensitivity [51] , [52] , [53] . We observed decreased sensitivity to sorafenib in Huh-7 spheroids than in cells grown as 2D monolayers ( Figure 5 A ).…”
Section: Discussionmentioning
confidence: 99%
“…The major role of the tumor microenvironment in cancer progression, metastasis and drug resistance has gained increased attention [ 11 , 12 ]. Recently, there have also been several studies on stroma-mediated drug resistance in tumors [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…These phenomena suggest that we could enhance the transport drug carrier across BBB via selecting a suitable mediated endocytosis or blocking the expression of P-gp protein [ 8 , 9 ]. MDR is defined as the resistance of tumor cells to the cytotoxic effects of many structurally and functionally related or unrelated chemotherapeutic drugs [ 10 ]. It leads to the metastasis and relapse of tumor, hence resulting in the failure of clinical treatment [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%